This clearance follows the recent activation of Bantam’s first U.S. clinical trial site at The University of Texas MD Anderson Cancer Center for its BTM-3566 Phase 1 study. BTM-3566 is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback